| Cholinergic neurotransmission is essential for perirhinal cortical plasticity and recognition memory EC Warburton, T Koder, K Cho, PV Massey, G Duguid, GRI Barker, ... Neuron 38 (6), 987-996, 2003 | 277 | 2003 |
| The different effects on recognition memory of perirhinal kainate and NMDA glutamate receptor antagonism: implications for underlying plasticity mechanisms GRI Barker, EC Warburton, T Koder, NP Dolman, JCA More, JP Aggleton, ... Journal of Neuroscience 26 (13), 3561-3566, 2006 | 127 | 2006 |
| Real world evidence (RWE)–a disruptive innovation or the quiet evolution of medical evidence generation? S Khosla, R White, J Medina, M Ouwens, C Emmas, T Koder, G Male, ... F1000Research 7, 2018 | 122 | 2018 |
| Benzodiazepine impairment of perirhinal cortical plasticity and recognition memory H Wan, EC Warburton, XO Zhu, TJ Koder, Y Park, JP Aggleton, K Cho, ... European Journal of Neuroscience 20 (8), 2214-2224, 2004 | 94 | 2004 |
| Open Pharma recommendations for plain language summaries of peer-reviewed medical journal publications A Rosenberg, S Baróniková, L Feighery, W Gattrell, RE Olsen, A Watson, ... Current Medical Research and Opinion 37 (11), 2015-2016, 2021 | 31 | 2021 |
| Open access policies of leading medical journals: a cross-sectional study TS Ellison, T Koder, L Schmidt, A Williams, CC Winchester BMJ open 9 (6), e028655, 2019 | 17 | 2019 |
| Real world evidence (RWE): a disruptive innovation or the quiet evolution of medical evidence generation? F1000Res. 2018; 7: 111 S Khosla, R White, J Medina, M Ouwens, C Emmas, T Koder | 8 | |
| Infographic: Open Pharma recommendations for plain language summaries of peer-reviewed medical journal publications A Rosenberg, S Baróniková, L Feighery, W Gattrell, R Egelund Olsen, ... Current Medical Research and Opinion 38 (6), 881-882, 2022 | 4 | 2022 |
| Real world evidence (RWE)—a disruptive innovation or the quiet evolution of medical evidence generation? F1000Research. 2018; 7: 111 S Khosla, R White, J Medina, M Ouwens, C Emmas, T Koder | 4 | |
| Assessing PubMed metatag usage for plain language summary discoverability A Rosenberg, S Baronikova, W Gattrell, N Ghildyal, T Koder, ... Poster presented at the 9th International Congress on Peer Review and …, 2022 | 1 | 2022 |
| Surveying the evolving models of digital publishing: where does pharma fit? A Williams, C Winchester, L Robinson, T Koder, C Rains, R Smith Curr Med Res Opin 33 (Suppl 1), 29, 2017 | 1 | 2017 |
| Measuring open access in pharmaceutical company-supported articles-an improved and semi-automated method E Bevan, T Koder, V Philippon, S Baronikova, L Miller, W Gattrell, T Rees CURRENT MEDICAL RESEARCH AND OPINION 38, 39-40, 2022 | | 2022 |
| How openly accessible is pharma-sponsored research? An informatics approach H Freeman, S Macdonald, S Baronikova, L Miller, V Philippon, T Koder, ... CURRENT MEDICAL RESEARCH AND OPINION 37, 28-28, 2021 | | 2021 |
| The uptake and use of medRxiv S Macdonald, S Sabir, T Koder CURRENT MEDICAL RESEARCH AND OPINION 36, 22-22, 2020 | | 2020 |
| How open are pharma publications? S Macdonald, T Koder CURRENT MEDICAL RESEARCH AND OPINION 36, 27-27, 2020 | | 2020 |
| Real world evidence (RWE)–a disruptive innovation or the quiet S Khosla, R White, J Medina, M Ouwens, C Emmas, T Koder, G Male, ... | | 2018 |
| the quiet evolution of medical evidence generation? S Khosla, R White, J Medina, M Ouwens, C Emmas, T Koder, G Male, ... | | 2018 |
| Is pharmaceutical industry research posted as preprints? H Lang, T Koder, CC Winchester CURRENT MEDICAL RESEARCH AND OPINION 34, 22-22, 2018 | | 2018 |
| Do journals restrict access to commercially funded research? T Ellison, L Schmidt, T Koder CURRENT MEDICAL RESEARCH AND OPINION 34, 33-33, 2018 | | 2018 |
| Driving innovations in medical publishing: The Open Pharma project. T Koder Medical Writing 26 (3), 2017 | | 2017 |